| Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More | Frank Vinluan | 08/14/20 | National |
| Beam Therapeutics Preps IPO and Sheds Light on Its Gene-Editing Drugs | Frank Vinluan | 09/27/19 | Boston |
| Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More | Ben Fidler | 02/08/19 | National |
| New CRISPR Fight: Old Friends Intellia, Caribou in License Dispute | Alex Lash | 02/06/19 | San Francisco |
| Biocom Opens New Bay Area Office, Forms Advisory Group | Sarah de Crescenzo | 09/18/18 | San Diego |
| CRISPR Pioneer Zhang Preaches Extra Caution In Human Gene Editing | Alex Lash | 07/31/17 | Boston |
| Roundup: Caringo, Aging 2.0, Disruptors Agenda, Cloud Sites, Trey Bowles | Angela Shah | 10/03/16 | Texas |
| Bio Roundup: CAR-T & Migraine Races, Intra-Cellular, Rockefeller & More | Ben Fidler | 09/30/16 | National |
| Caribou CEO Touts Incubator’s Role Translating Science into Startup | David Holley | 09/29/16 | Texas |
| Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More | Ben Fidler | 06/24/16 | National |
| The Biotech Roundup: Immunotherapy Ups And Downs, Gene Deals & More | Alex Lash | 05/20/16 | National |
| Agenovir Gets $10.6M To Take on Viral Infections With CRISPR | David Holley | 05/18/16 | San Francisco |
| Caribou Biosciences Secures $30,000,000 Series B Funding Round | VentureDeal | 05/16/16 | San Francisco |
| West Coast Biotech Roundup: Alfred Mann, ResMed, Illumina, & More | Bruce V. Bigelow | 02/26/16 | San Diego |
| West Coast Bio Roundup: CRISPR Patent, HCV Data, Verily Digs & More | Alex Lash | 02/19/16 | San Francisco |
| Caribou Bio’s New CRISPR Patent Isn’t About Gene Editing | Alex Lash | 02/18/16 | San Francisco |
| New Speakers Join Gene-Edit, Microbiome, Big Data “Disruptors” 12/10 | Alex Lash | 12/02/15 | San Francisco |
| Agenda Posted: Xconomy’s Bay Area Life Science Disruptors On Dec. 10 | Alex Lash | 11/19/15 | San Francisco |
| Join Xconomy Dec. 10 To Hear From Bay Area Life Science Disruptors | Alex Lash | 11/12/15 | San Francisco |
| Even With New Crowdfunding Rules, No Easy Path Forward For Biotechs | Alex Lash | 11/03/15 | National |
| West Coast Biotech Roundup: Caribou, Amgen, CytomX, Arena & More | Alex Lash | 10/08/15 | Boston |
| CRISPR Race Heats Up As Gates, Crossovers Put $120M Into Editas | Ben Fidler | 08/10/15 | Boston |
| Juno, Editas To Collaborate On CRISPR-Juiced Cancer Immunotherapy | Alex Lash | 05/27/15 | Seattle |
| Bay Area Fund, Aligned With UC, Raises New To Cash To Seed Biotechs | Alex Lash | 05/12/15 | San Francisco |
| East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More | Ben Fidler | 04/24/15 | Boston |
| Caribou Biosciences Secures $11,000,000 Series A Financing Round | VentureDeal | 04/03/15 | San Francisco |
| Doudna’s Caribou Bio Raises $11M To Expand Uses For Gene Editing Tech | Bernadette Tansey | 04/02/15 | San Francisco |
| Amid Gene Editing Worry, A Return To Biotech’s 1st “Asilomar Moment” | Victor McElheny | 03/26/15 | Boston |
| Ready, Aim, CRISPR: Will Gene-Editing Tools Hit Their Targets? | Alex Lash | 02/17/15 | National |
| CART + CRISPR = 1st-Of-Its-Kind Biotech Deal From Novartis, Intellia | Alex Lash | 01/07/15 | Boston |
